StreetInsider.com Pre-Open Movers:

Acorda Therapeutics, Inc. (Nasdaq: ACOR) 154% HIGHER; announced positive results from its Phase 3 clinical trial ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE